Clinical significance of soluble PD-L1 level in hepatocellular carcinoma patients treated with RT

被引:0
|
作者
Kim, H. J. [1 ]
Park, S. [1 ]
Kim, K. J. [1 ]
Seong, J. [1 ]
机构
[1] Yonsei Univ, Radiat Oncol, Seoul, South Korea
关键词
D O I
10.1016/S0167-8140(18)30360-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OC-0050
引用
收藏
页码:S21 / S22
页数:2
相关论文
共 50 条
  • [1] The Clinical Implications of Soluble PD-L1 in Hepatocellular Carcinoma Patients Treated With Radiation Therapy
    Kim, H. J.
    Park, S.
    Kim, K. J.
    Seong, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S89 - S89
  • [2] Soluble PD-L1 and prognosis of patients with hepatocellular carcinoma
    Luo, Cheng-Piao
    Mo, Han-Yue
    Wu, Ling-Ling
    Ma, Yun
    Peng, Ning-Fu
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 71 : 117 - 118
  • [3] Clinical Significance of Soluble PD-1 and PD-L1 in Plasma of NSCLC Patients Treated with Immune Checkpoint Inhibitors
    Nakahara, Y.
    Himuro, H.
    Igarashi, Y.
    Kouro, T.
    Higashijima, N.
    Matsuo, N.
    Murakami, S.
    Wei, F.
    Horaguchi, S.
    Tsuji, K.
    Mano, Y.
    Saito, H.
    Azuma, K.
    Naoki, K.
    Sasada, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S614 - S614
  • [4] POTENTIAL AS BIOMARKERS OF SOLUBLE PD-1 AND PD-L1 IN HEPATOCELLULAR CARCINOMA
    Kanzaki, Hiroaki
    Chiba, Tetsuhiro
    Kato, Naoya
    [J]. HEPATOLOGY, 2019, 70 : 1218A - 1218A
  • [5] Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
    Niu, Mengke
    Liu, Yiming
    Yi, Ming
    Jiao, Dechao
    Wu, Kongming
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] The clinical significance of soluble PD-1 and PD-L1 in lung cancer
    Abu Hejleh, Taher
    Furqan, Muhammad
    Ballas, Zuhair
    Clamon, Gerald
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 143 : 148 - 152
  • [7] Prognostic Value of PD-L1 in Patients with Hepatocellular Carcinoma
    Pei, Renguang
    Zhang, Weixuan
    Wang, Sufen
    Huang, Xi
    Zou, Yinghua
    [J]. CLINICAL LABORATORY, 2019, 65 (05) : 693 - 698
  • [8] Expression and clinical significance of PD-1, PD-L1 and PARP-1 in hepatocellular carcinoma and paracancerous tissues
    Yang, X.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1898 - 1898
  • [9] Measurement of soluble PD-1 and soluble PD-L1 as well as PD-L1 and PD-1 from perioperative patients with gastric carcinoma
    Wei, Hangzhi
    Wu, Fahong
    Mao, Yudong
    Zhang, Youcheng
    Leng, Guangxian
    Wang, Jia
    Zhang, Wei
    Wang, Tianwei
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (04) : 331 - 345
  • [10] The expression and clinical significance of PD-L1 in patients with upper tract urothelial carcinoma
    Sheng, Xinan
    He, Zhisong
    Kong, Yan
    Chi, Zhihong
    Si, Lu
    Cui, Chuanliang
    Tang, Bixia
    Mao, Li Li
    Wang, Xuan
    Lian, Bin
    Yan, Xieqiao
    Li, Si Ming
    Dai, Jie
    Guo, Jun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)